Clinical trial
Cyclosporine In Takotsubo Syndrome (CIT) Trial
NCT05946772 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cyclosporine In Takotsubo Syndrome (CIT) Trial
- Lead sponsor
- University Hospital Heidelberg
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- February 1, 2025
- Completion date
- February 29, 2028
- Enrollment
- 204 (estimated)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.